SNY
$45.99
Revenue | $12205Mn |
Net Profits | $-801Mn |
Net Profit Margins | -6.56% |
Sanofi’s revenue jumped 59.94% since last year same period to $12205Mn in the Q4 2025. On a quarterly growth basis, Sanofi has generated -7.33% fall in its revenue since last 3-months.
Sanofi’s net profit fell -260.52% since last year same period to $-801Mn in the Q4 2025. On a quarterly growth basis, Sanofi has generated -128.59% fall in its net profits since last 3-months.
Sanofi’s net profit margin fell -200.36% since last year same period to -6.56% in the Q4 2025. On a quarterly growth basis, Sanofi has generated -130.85% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.05 |
EPS Estimate Current Year | 1.05 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 1.05 - a 25% jump from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 1.05.
Earning Per Share (EPS) | 0 |
Sanofi’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Sanofi has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-23 | 1.05 | 0 | -100% |